Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Dianthus Therapeutics (DNTH)
- 89.770
- -1.890-2.06%
Close Apr 10 16:00 ET
- 89.770
- 0.0000.00%
Post 20:01 ET
4.89BMarket Cap-21.37P/E (TTM)
92.250High88.000Low481.15KVolume92.000Open91.660Prev Close43.12MTurnover0.94%Turnover RatioLossP/E (Static)54.45MShares92.27352wk High9.91P/B4.61BFloat Cap16.63552wk Low--Dividend TTM51.40MShs Float336.000Historical High--Div Yield TTM4.64%Range %5.136Historical Low89.612Avg Price1Lot Size
Dianthus Therapeutics (DNTH) Key Financial Indicators
DNTH Earnings per Share (EPS)
According to the latest financial report of Dianthus Therapeutics, the latest earnings per share (TTM) for the company is -1.43. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
DNTH Free Cash Flow (FCF)
Interested in knowing about Dianthus Therapeutics's free cash flow? The latest report shows it as -47.12M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
DNTH Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dianthus Therapeutics shows that the company's current ratio is 13.32, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
DNTH Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dianthus Therapeutics, the quick ratio is 13.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
DNTH Return on Equity (ROE)
Want to learn more about the financial health of Dianthus Therapeutics? The latest ROE figure is -12.39%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
DNTH Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dianthus Therapeutics, the total asset return on investment (ROA) is -11.63%.
Currency: USD
Quarterly
Loading...
DNTH Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dianthus Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
DNTH Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dianthus Therapeutics, the net profit margin is -22.69K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm